Pharmaceutical combination of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone and N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-Glutamic acid
STEFANIC, MARTIN FRIEDRICH,HILBERG, FRANK,KAISER, ROLF,SHAPIRO, DAVID
申请号：
NZ58895709
公开号：
NZ588957A
申请日:
2009.06.04
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
Disclosed is the use of the compound 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2- indolinone or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for simultaneous, separate or sequential 5 use with the compound N-[4-[2-(2- amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]- L-Glutamic acid or a pharmaceutically acceptable salt thereof, in the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis, in a human or non-human mammalian body.
